REGNRegeneron PharmaceuticalsHealth Care
$794.19EarningsOct 28, 2026
1D—1W—1M—3M—1Y—
Market cap$84.8BCompany infoRevenue$15.5B52-wk range$556 – $841IndustryBiotechnologyWebsiteregeneron.comRelated
Yahoo
EDGAR
CNN
FinvizMarket Beat
Perform
n/a
1 Year
n/a1 Month
n/a1 Week
n/a1 Day
Rank Durability
Persist
n/a
1 Year
n/a6 Month
n/a3 Month
n/aTrend Hold
Business Beat
Profit
n/a
Composite
n/aRevenue
n/aMargin
n/aCash Flow
Money Flow
Pressure
n/a
60 Day
n/a30 Day
n/a5 Day
n/a2 Day
▲ +38.4% · 1YSPY
Weekly rank vs S&P 500 · 52wk
Not enough history to plot
ValuationHow the price is priced — vs cohort and vs its own past
MetricValueUnivSect5-yr range
P / E19.6×6480
9
28
P / S5.5×2637
4
9
P / FCF24.1×4045
9
38
EV / EBITDA15.1×4563
7
22
P / E (fwd)14.6×——
ProfitabilityMargins and returns on capital
MetricValueUnivSect5-yr range
Gross margin84.9%9690
83%
86%
Operating margin25.6%7679
24%
56%
Net margin27.9%8891
28%
52%
ROE17.5%6066
14%
45%
ROIC9872009.4%100100
9%
9872009%
Financial healthLeverage and liquidity
MetricValueUnivSect5-yr range
Debt / equity0.068776
0.1
0.1
Net debt / EBITDA0.0×7368
Current ratio3.348780
Interest coverage71.7×8781
Per shareTTM, with year-over-year change
Revenue / share$145.46▲ +9%
EPS (diluted)$40.43▲ +2%
FCF / share$32.98▼ −8%
Est. EPS growth (fwd)+12%